THE CHINA FUND, INC. (CHN)

MONTHLY INSIGHT

 

 

 

31 DECEMBER, 2011

 

IN BRIEF
Net asset value per share	US$24.12
Market price	US$22.00
Premium/(discount)	(8.79%)
Fund size	US$549.5m

 

Source: State Street Bank and Trust Company.

 

At 31 January, 2012		US$ return
	China Fund	MSCI Golden
	NAV	Dragon*
	%	%
One month	3.7	10.0
Year to date	3.7	10.0
One year	(18.5)	(11.2)
Three years % pa	22.3	22.3

 

Past performance is not a guide to future returns.

Source: State Street Bank and Trust Company.

NAV performance. *Source for index data: MSCI.

 

 

FUND MANAGERS (interim)

 

Wong Kok Hoi			James Liu

 

MANAGER’S COMMENTARY

 

The divergence between different Chinese equity markets continued from December into the first week of 2012, with the MSCI China index up 0.4% while the CSI 300 lost 2.4%. Shares listed offshore were apparently helped by rising risk appetite and liquidity inflows, but this was not the case for the insulated A-share market. However, as strong economic data from China, the United States, Germany and the United Kingdom boosted sentiment, both the offshore and onshore markets rallied for the remainder of January. The MSCI Golden Dragon index finished the month 10.0% higher, with the CSI 300 up 4.8%.

 

As domestic inflation abates and uncertainties continue in Europe, there is growing consensus that the Chinese authorities’ tightening of monetary policy is coming to an end. But the market’s expectations of loosening have so far been disappointed. The CPI rose 4.1% year on year in December 2011, down 10 basis points from November 2011 and marking a straight five-month decline from the 37-month high of 6.5% last July. Following Premier Wen Jiabao’s comments on fine-tuning policy to deal with a tough first quarter of 2012, the China Securities Regulatory Commission encouraged state-owned companies to increase their stakes in their listed subsidiaries. After the central bank reduced the reserve-requirement ratio (RRR) by 50 basis points on December 5, 2011, the market expected further cuts at the end of the month and before the Chinese New Year. Neither materialized, which put some pressure on equities, in particular those traded in Shanghai and Shenzhen.

 

Recently released macroeconomic data were encouraging. GDP in the last quarter of 2011 was up 8.9% from a year ago, beating market expectations. The official Purchasing Managers’ Index (PMI) rose to 50.5 in January from 50.3 in the previous month. This surpassed expectations and is the highest reading since October, indicating that the economic slowdown is stabilizing and alleviating concerns about a ‘hard landing’ in the Chinese economy. Backing the official PMI reading, a similar HSBC survey showed that the PMI slowed the least in the last three months.

 

The Taiwan Stock Exchange index had a stellar start to the year. It rose 6.3% in January, even though the exchange was closed for 10 days for the Chinese New Year holiday. Recent developments in the Greek sovereign-debt negotiations have clearly eased some of the market’s concern over a disorderly default. Further boosted by increasing optimism about the US economy, capital began to flow back to emerging markets, including Taiwan. And President Ma Ying-Jeou was re-elected for a second term in office. His victory removes uncertainty over the future of his cross-strait policies, which affect the many Taiwanese businesses with key markets or production bases in mainland China. The Taiwan dollar appreciated by 2.3% in January.

 

Source: Martin Currie Inc. and APS Asset Management Pte Ltd.

FUND MANAGEMENT

 

As of November 9, 2011, the Fund entered into an Interim Investment Advisory and Management Agreement with Martin Currie Inc. and on November 10, 2011, Martin Currie Inc. entered into an Interim Sub-Advisory Agreement with APS Asset Management Pte Ltd. to manage the Fund’s portfolio until new permanent management arrangements can be put in place.

 

On January 6, 2012, the Fund announced that the Board of Directors has appointed RCM Asia Pacific Limited (‘RCM’) as the investment adviser of the Fund subject to stockholder approval. RCM began managing the Fund on February 12, 2012 on an interim basis until stockholder approval of the new management agreements is obtained. The new investment management agreements with RCM will be submitted to stockholders for approval at the Fund’s annual stockholders’ meeting. The Board also set March 8, 2012 as the date of the Fund’s annual stockholders meeting, with January 23, 2012 being the record date for that meeting.

 

For further information please go to www.chinafundinc.com.

 

MONTHLY INSIGHT

 

 

FUND DETAILS
Market cap	US$501.2m
Shares outstanding	22,781,762
Exchange listed	NYSE
Listing date	July 10, 1992
Listing and direct investment manager	Martin Currie Inc

 

Source: State Street Bank and Trust Company.

 

ASSET ALLOCATION

 

 

 

Source: State Street Bank and Trust Company

 

INDUSTRY ALLOCATION 

	The China Fund, Inc %	MSCI Golden Dragon %
Healthcare	24.4	0.4
Consumer discretionary	17.0	6.9
Information technology	15.8	35.4
Financials	15.2	19.3
Consumer staples	13.7	3.3
Industrials	4.6	6.6
Utilities	3.9	4.1
Materials	2.0	6.8
Telecommunications	1.4	7.8
Energy	0.6	9.5
Other assets & liabilities	1.4	—

 

Source: State Street Bank and Trust Company. Source for index data: MSCI

 

PERFORMANCE

(US$ RETURNS)

	NAV %	Market price %
One month	3.7	7.3
Year to date	3.7	7.3
Three years % pa	22.3	23.2

 

Past performance is not a guide to future returns.

Three year returns are annualized.

Source: State Street Bank and Trust Company

  

15 LARGEST HOLDINGS (53.4%)	Fund %
China Medical System Holdings	Healthcare		10.2
Hand Enterprise Solutions	Information technology		4.5
Ping An Insurance	Financials		4.3
FamilyMart	Consumer discretionary		3.6
Ruentex Development Co	Financials		3.5
Shandong Weigao Group	Healthcare		3.1
China Bright	Healthcare		3.0
Far Eastern Department Stores	Consumer discretionary		2.9
Zong Su Foods	Consumer staples		2.9
Uni-President Enterprises Corp.	Consumer staples		2.9
ENN Energy	Utilities		2.8
Sinopharm Group	Healthcare		2.6
Huiyin Household Appliances	Consumer discretionary		2.5
CITIC Securities Co	Financials		2.4
WuXi PharmaTech Cayman	Healthcare		2.2

 

 

 

DIRECT INVESTMENTS (5.9%)	Fund %
China Bright	Healthcare		3.0
Zong Su Foods	Consumer staples		2.9
China Silicon	Information technology		0.0
Source: State Street Bank and Trust Company

 

FUND PERFORMANCE (BASED ON NET ASSET VALUE)																			(US$ returns)
	One month			Three months			Calendar year			One year			Three years			Five years			Since launch
		%			%			to date %			%			% pa			% pa			% pa
The China Fund, Inc.		3.7			(4.4	)		3.7			(18.5	)		22.3			9.8			10.8
MSCI Golden Dragon		10.0			3.2			10.0			(11.2	)		22.3			4.0			n/a
Hang Seng Chinese Enterprise		13.9			7.6			13.9			(9.6	)		16.6			3.5			n/a
Shanghai Stock Exchange 180		6.1			(6.0	)		6.1			(14.0	)		8.2			3.5			n/a

 

Past performance is not a guide to future returns. Source: State Street Bank and Trust Company. Launch date July 10, 1992. Three, five year and since launch returns are all annualized. Source for index data: MSCI for the MSCI Golden Dragon and Copyright 2012 Bloomberg LP for the Hang Seng China Enterprise and the Shanghai Stock Exchange 180. For a full description of each index please see the index descriptions section.

 

 

PERFORMANCE IN PERSPECTIVE

 

 

 

Past performance is not a guide to future returns.

Source: Martin Currie Inc as at 31 January, 2012.

 

 

MONTHLY INSIGHT

 

 

 

 

Past performance is not a guide to future returns.

Source: Martin Currie Inc as at 31 January, 2012.

 

 

 

 

 

	2001			2002			2003			2004			2005			2006			2007			2008			2009			2010			2011
Total		0.13			0.21			1.78			3.58			2.51			4.01			12.12			5.82			0.26			2.27			2.99
Income		0.13			0.06			0.07			0.20			0.22			0.30			0.28			0.48			0.26			0.37			0.17
Long-term capital		0.00			0.00			0.67			3.27			2.29			2.73			9.00			5.34			0.00			1.90			2.82
Short-term capital		0.00			0.15			1.04			0.11			0.00			0.98			2.84			0.00			0.00			0.00			0.00

  

Past performance is not a guide to future returns.

Source: State Street Bank and Trust Company.

 

   

Sector	Company (BBG ticker)			Price	Holding		Value US$	% of portfolio
HONG KONG H								22.2
China Medical System Holdings	867		HK	HK$5.1	86,093,200		$56,279,497	10.2
Shandong Weigao Group Medical Polymer	1066		HK	HK$7.1	18,352,000		$16,800,227	3.1
Sinopharm Group	1099		HK	HK$18.4	6,056,800		$14,369,262	2.6
Citic Securities	6030		HK	HK$15.3	6,688,500		$13,211,767	2.4
Wumart Stores	1025		HK	HK$16.0	4,547,750		$9,358,427	1.7
Asian Citrus Holdings	73		HK	HK$4.2	8,814,000		$4,795,776	0.9
Fook Woo	923		HK	HK$1.4	25,314,000		$4,471,516	0.8
Shandong Chenming Paper Holdings	1812		HK	HK$3.8	6,072,196		$2,943,791	0.5
TAIWAN								21.6
FamilyMart	5903		TT	NT$129.0	4,501,652		$19,626,974	3.6
Ruentex Development Co	9945		TT	NT$36.6	15,636,301		$19,315,819	3.5
Far Eastern Department Stores	2903		TT	NT$39.9	11,922,460		$16,077,944	2.9
Uni-President Enterprises Corp.	1216		TT	NT$43.7	10,625,335		$15,693,355	2.9
Yuanta Financial Holdings	2885		TT	NT$16.7	19,305,680		$10,896,658	2.0
W T Microelectronics	3036		TT	NT$43.6	7,122,000		$10,494,945	1.9
China Metal Products	1532		TT	NT$20.2	12,420,374		$8,458,658	1.5
KGI Securities	6008		TT	NT$12.5	17,321,078		$7,317,735	1.3
Test-Rite International	2908		TT	NT$21.5	8,457,000		$6,131,057	1.1
Taiwan Life 4percent Conv Bond*			n/a	NT$66.8	200,000,000		$4,512,108	0.9
HONG KONG								19.2
Enn Energy	2688		HK	HK$23.6	5,084,000		$15,437,247	2.8
Huiyin Household Appliances	1280		HK	HK$0.7	160,413,750		$14,064,487	2.5
Shenzhen International Holdings	152		HK	HK$0.5	150,090,000		$10,256,543	1.9
Ajisen China Holdings	538		HK	HK$8.9	6,945,000		$7,996,448	1.4
Far East Horizon	3360		HK	HK$7.4	7,898,000		$7,535,677	1.4
Ports Design	589		HK	HK$12.7	4,549,500		$7,449,735	1.4
Natural Beauty Bio-Technology	157		HK	HK$1.2	47,710,000		$7,381,831	1.3
Tencent Holdings	700		HK	HK$189.7	291,000		$7,117,603	1.3
Shangri-La Asia	69		HK	HK$16.1	3,316,683		$6,902,094	1.3
China Water Affairs	855		HK	HK$2.4	19,976,000		$6,129,977	1.1
Golden Meditech Co	801		HK	HK$1.1	35,040,000		$4,879,342	0.9
China Shineway Pharmaceutical Group	2877		HK	HK$11.2	3,041,000		$4,383,607	0.8
China Innovationpay Group	8083		HK	HK$0.2	146,000,000		$3,219,010	0.6
Chaoda Modern Agriculture (Holdings)	682		HK	HK$0.8	26,651,357		$2,834,958	0.5
FUJI Food & Catering Services	1175		HK	HK$0.0	5,462,000		$0	0.0
EQUITY LINKED SECURITIES (‘A’ SHARES)								14.3
Ping An Insurance			n/a	US$6.1	3,870,559		$23,523,377	4.3
Wuliangye Yibin			n/a	US$5.1	2,334,507		$11,835,418	2.1
ZTE Corp			n/a	US$2.3	4,099,499		$9,617,593	1.8
Ufida Software			n/a	US$2.6	3,616,072		$9,429,244	1.7
China United Network Communications			n/a	US$0.8	9,809,037		$7,587,869	1.4
Suning Appliance			n/a	US$1.4	4,607,872		$6,349,647	1.1
Shanghai Yuyuan Tourist			n/a	US$1.4	429,303,600		$6,199,500	1.1
Qinghai Salt Lake Potash			n/a	US$5.2	814,450		$4,202,322	0.8
USA								8.1
WuXi PharmaTech Cayman	WX		US	US$13.6	883,490		$11,997,794	2.2
Hollysys Automation Technologies	HOLI		US	US$9.7	925,700		$8,988,547	1.6
Mindray Medical International	MR		US	US$29.8	291,700		$8,680,992	1.6
VanceInfo Technologies	VIT		US	US$12.6	474,800		$5,968,236	1.1
China New Borun Corp.	BORN		US	US$4.5	1,202,859		$5,424,894	1.0
Far East Energy	FEEC		US	US$0.3	10,303,847		$3,348,750	0.6

 

*

This is an unlisted convertible bond. Shares in Taiwan Life are listed on the Taiwan Stock Exchange.

 

 

MONTHLY INSIGHT

 

 

 

 

Sector	Company (BBG ticker)			Price	Holding		Value US$	% of portfolio
DIRECT								5.9
China Bright			n/a	HK$8.7	14,665,617		$16,526,663	3.0
Zong Su Foods			n/a	US$5,977.0	2,677		$16,000,429	2.9
China Silicon Corp.			n/a	US$0.0	2,329,281		$0	0.0
CHINA ‘A’ SHARE								4.5
Hand Enterprise Solutions	300170		CH	Rmb13.8	11,238,137		$24,512,446	4.5
SINGAPORE								2.8
China Fishery Group	CFG		SP	SG$1.1	13,594,872		$11,672,665	2.1
CDW Holding	CDW		SP	SG$0.1	47,602,000		$3,708,706	0.7
OTHER ASSETS & LIABILITIES							$7,610,214	1.4

 

 

 

INDEX DESCRIPTIONS

 

MSCI Golden Dragon Index

 

The MSCI Golden Dragon is a free float-adjusted market capitalization index that is designed to measure equity market performance in the China region. As of May 2005 the MSCI Golden Dragon Index consisted of the following country indices: China, Hong Kong and Taiwan.

 

Hang Seng China Enterprise Index

 

The Hang Seng China Enterprise Index is a capitalization-weighted index comprised of state-owned Chinese companies (H-shares) listed on the Hong Kong Stock Exchange and included in Hang Seng Mainland China index.

 

Shanghai Stock Exchange 180 Index

 

The Shanghai Stock Exchange 180 ‘A’ Share Index is a capitalization-weighted index. The index tracks the daily price performance of the 180 most representative ‘A’ share stocks listed on the Shanghai Stock Exchange.

 

 

OBJECTIVE

 

The investment objective of the Fund is to achieve long term capital appreciation. The Fund seeks to achieve its objective through investment in the equity securities of companies and other entities with significant assets, investments, production activities, trading or other business interests in China or which derive a significant part of their revenue from China.

 

The Fund has an operating policy that the Fund will invest at least 80% of its assets in China companies. For this purpose, ‘China companies’ are (i) companies for which the principal securities trading market is in China; (ii) companies for which the principal securities trading market is outside of China or in companies organized outside of China, that in both cases derive at least 50% of their revenues from goods or services sold or produced, or have a least 50% of their assets in China; or (iii) companies organized in China. Under the policy, China will mean the People’s Republic of China, including Hong Kong, and Taiwan. The Fund will provide its stockholders with at least 60 days’ prior notice of any change to this policy.

 

CONTACTS

 

The China Fund, Inc.

c/o State Street Bank and Trust Company

2 Avenue de Lafayette

PO Box 5049

Boston, MA 02206-5049

Tel: (1) 888 CHN-CALL (246 2255)

www.chinafundinc.com

 

 

 

 

IMPORTANT INFORMATION

 

This document is issued and approved by Martin Currie Inc (MC Inc), as investment adviser of The China Fund Inc (the Fund). MC Inc is authorised and regulated by the Financial Services Authority (FSA) and incorporated under limited liability in New York, USA. Registered in Scotland (No BR2575), registered address Saltire Court, 20 Castle Terrace, Edinburgh, EH1 2ES. Information herein is believed to be reliable but has not been verified by MC Inc. MC Inc makes no representation or warranty and does not accept any responsibility in relation to such information or for opinion or conclusion which the reader may draw from the newsletter.

 

The Fund is classified as a 'non-diversified' investment company under the US Investment Company Act of 1940 as amended. It meets the criteria of a closed ended US fund and its shares are listed on the New York Stock Exchange. MC Inc has been appointed investment adviser to the Fund.

 

Investors are advised that they will not generally benefit from the rules and regulations of the United Kingdom Financial Services and Markets Act 2000 and the FSA for the protection of investors, nor benefit from the United Kingdom Financial Services Compensation Scheme, nor have access to the Financial Services Ombudsman in the event of a dispute. Investors will also have no rights of cancellation under the FSA's Conduct of Business Sourcebook of the United Kingdom.

 

This newsletter does not constitute an offer of shares. MC Inc, its ultimate and intermediate holding companies, subsidiaries, affiliates, clients, directors or staff may, at any time, have a position in the market referred to herein, and may buy or sell securities, currencies, or any other financial instruments in such markets. The information or opinion expressed in this newsletter should not be construed to be a recommendation to buy or sell the securities, commodities, currencies or financial instruments referred to herein.

 

The information provided in this report should not be considered a recommendation to purchase or sell any particular security. There is no assurance that any securities discussed herein will remain in an account's portfolio at the time you receive this report or that securities sold have not been repurchased.

 

It should not be assumed that any of the securities transactions or holdings discussed here were or will prove to be profitable, or that the investment recommendations or decisions we make in the future will be profitable or will equal the investment performance of the securities discussed herein.

 

Investing in the Fund involves certain considerations in addition to the risks normally associated with making investments in securities. The value of the shares issued by the Fund, and the income from them, may go down as well as up and there can be no assurance that upon sale, or otherwise, investors will receive back the amount originally invested. There can be no assurance that you will receive comparable performance returns, or that investments will reflect the performance of the stock examples contained in this document. Movements in foreign exchange rates may have a separate effect, unfavorable as well as favorable, on the gain or loss otherwise experienced on an investment. Past performance is not a guide to future returns. Accordingly, the Fund is only suitable for investment by investors who are able and willing to withstand the total loss of their investment. In particular, prospective investors should consider the following risks:

 

–

The companies quoted on Greater Chinese stock exchanges are exposed to the risks of political, social and religious instability, expropriation of assets or nationalisation, rapid rates of inflation, high interest rates, currency depreciation and fluctuations and changes in taxation, which may affect income and the value of investments.

 

–

At present, the securities market and the regulatory framework for the securities industry in China is at an early stage of development. The China Securities Regulatory Commission (CSRC) is responsible for supervising the national securities markets and producing relevant regulations. The Investment Regulations, under which the Fund invests in the People's Republic of China (PRC) and which regulate repatriation and currency conversion, are new. The Investment Regulations give CSRC and State Administration of Foreign Exchange (SAFE) wide discretions and there is no precedent or certainty as to how these discretions might be exercised, either now or in the future. The Fund may, from time to time, obtain access to the securities markets in China via Access Products. Such products carry additional risk and may be less liquid than the underlying securities which they represent.

 

–

During the past 15 years, the PRC government has been reforming the economic and political systems of the PRC, and these reforms are expected to continue, as evidenced by the recently announced changes. The Fund's operations and financial results could be adversely affected by adjustments in the PRC's state plans, political, economic and social conditions, changes in the policies of the PRC government such as changes in laws and regulations (or the interpretation thereof), measures which may be introduced to control inflation, changes in the rate or method of taxation, imposition of additional restrictions on currency conversion and the imposition of additional import restrictions.

 

–

PRC's disclosure and regulatory standards are in many respects less stringent than standards in certain Organisation for Economic Co-operation and Development (OECD) countries, and there may be less publicly available or less reliable information about PRC companies than is regularly published by or about companies from OECD countries.

 

–

The Shanghai Stock Exchange and Shenzhen Stock Exchange have lower trading volumes than most OECD exchanges and the market capitalisations of listed companies are small compared to those on more developed exchanges in developed markets. The listed equity securities of many companies in the PRC are accordingly materially less liquid, subject to greater dealing spreads and experience materially greater volatility than those of OECD countries. These factors could negatively affect the Fund's NAV.

 

–	The Fund invests primarily in securities denominated in other currencies but its NAV will be quoted in US dollars. Accordingly, a change in the value of such securities against US dollars will result in a corresponding change in the US dollar NAV.

 

–

The marketability of quoted shares may be limited due to foreign investment restrictions, wide dealing spreads, exchange controls, foreign ownership restrictions, the restricted opening of stock exchanges and a narrow range of investors. Trading volume may be lower than on more developed stockmarkets, and equities are less liquid. Volatility of prices can also be greater than in more developed stockmarkets. The infrastructure for clearing, settlement and registration on the primary and secondary markets may be underdeveloped. Under certain circumstances, there may be delays in settling transactions in some of the markets.

  

 

 

Martin Currie Inc registered in Scotland (no BR2575)

 

Registered office: Saltire Court, 20 Castle Terrace, Edinburgh EH1 2ES

Tel: 44 (0) 131 229 5252 Fax: 44 (0) 131 228 5959 www.martincurrie.com

 

North American office: 1350 Avenue of the Americas, Suite 3010, New York, NY

10019, USA Tel: (1) 212 258 1900 Fax: (1) 212 258 1919

 

Authorised and regulated by the Financial Services Authority and incorporated with

limited liability in New York, USA. Registered with the SEC as an investment adviser.

 

Please note: calls to the above numbers may be recorded.